Freda Lewis-Hall

Dr. Freda Lewis-Hall is a physician, researcher, and biopharmaceutical executive with more than four decades of experience translating scientific innovation into real-world impact—advancing drug and diagnostics development while reshaping how patients engage with their care. Her work spans the full continuum of innovation, from early discovery to implementation, with a consistent focus on areas of high unmet need. Her efforts include advancing women’s health and addressing gaps across age, geography, and disease—bringing greater precision and equity to how innovation reaches patients. A recognized leader in integrating the patient voice into healthcare, she has helped transform how patient insights inform development, regulatory strategy, and outcomes—strengthening both scientific rigor and real-world relevance. Dr. Lewis-Hall is a leading advocate for drug repurposing, advancing capital-efficient strategies that unlock new therapeutic value from existing medicines. Her approach accelerates timelines, reduces risk, and delivers meaningful outcomes for both patients and investors. As Managing Director of INTELMED LLC, she operates at the intersection of science, investment, and patient engagement. Her work includes advancing scalable, evidence-based approaches to patient education as a critical driver of health outcomes. Previously, she served as Executive Vice President, Chief Medical Officer, and Chief Patient Officer at Pfizer and held leadership roles at Vertex, Bristol Myers Squib, Pharmacia and Eli Lilly. She serves on a number public private and non-profit boards.